Emicizumab-kxwh Subcutaneous and LarkaDrin Capsules
Determining the interaction of Emicizumab-kxwh Subcutaneous and LarkaDrin Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emicizumab
Brand name: Hemlibra, Hemlibra 105 mg/07 mL, Hemlibra 60 mg/04 mL
Synonyms: Emicizumab
Generic Name: acetaminophen / dichloralphenazone / isometheptene mucate
Brand name: Nodolor
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emicizumab-kxwh Subcutaneous-Laronidase
- Emicizumab-kxwh Subcutaneous-Laronidase Intravenous
- Emicizumab-kxwh Subcutaneous-Larotrectinib
- Emicizumab-kxwh Subcutaneous-Larotrectinib Capsules
- Emicizumab-kxwh Subcutaneous-Larotrectinib Oral Solution
- Emicizumab-kxwh Subcutaneous-Larotrectinib Sulfate
- LarkaDrin Capsules-Emla
- LarkaDrin Capsules-Emla Topical
- LarkaDrin Capsules-Emo-Cort Scalp Solution Topical application
- LarkaDrin Capsules-Emo-Cort Topical application
- LarkaDrin Capsules-Emoquette
- LarkaDrin Capsules-Empagliflozin